Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
“Development of a probabilistic network for clinical pathways based on patient cohort characteristics, outcome-indicators and clinical workflow analysis to create artificial patients with prostatic adenocarcinoma” Andrea Riedel Institute for general practitioners PLCO Oct 8, 2019 PLCO-535
Development of a Risk Analysis and Breast Cancer Education Application Rumaisha Afiqah Taqiyya Bandung Institute of Technology PLCO Oct 7, 2024 PLCO-1698
Development of a sensitive and specific blood test for colon cancer by measuring base-specific hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC) in circulating cell-free DNA Marc Bissonnette University of Chicago PLCO Jan 24, 2018 2016-0057
Development of a Woman-Specific Risk Model for Participation in Lung Cancer CT Screening Marie-Pierre Revel APHP NLST Apr 29, 2024 NLST-1237
Development of a Woman-Specific Risk Model for Participation in Lung Cancer CT Screening Marie-Pierre Revel APHP PLCO Apr 29, 2024 PLCO-1538
Development of biomarkers of aging and health outcomes in chest X-ray images using deep learning Yasuhito Mitsuyama Osaka Metropolitan University NLST Dec 4, 2023 NLST-1108
Development of biomarkers of aging and health outcomes in chest X-ray images using deep learning Yasuhito Mitsuyama Osaka Metropolitan University PLCO Aug 8, 2023 PLCOI-1285
Development of CAD for lung nodule screening Naïm Jalal GE HEALTHCARE NLST Oct 27, 2022 NLST-977
Development of CADx for pulmonary nodules Timor Kadir Mirada Medical Ltd. NLST Jul 15, 2015 NLST-143
Development of CADx for pulmonary nodules Lyndsey Pickup Optellum Ltd. NLST Oct 13, 2016 NLST-251
Development of cell-free DNA (cfDNA) 5-hydroxymethylcytosine (5hmC) biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) Marc Bissonnette University of Chicago PLCO Jan 15, 2021 2020-1003
Development of clinically applied recurrence prediction model through artificial intelligence Sung Yong Kim Infinitt Healthcare co,ltd NLST Mar 10, 2021 NLST-767
Development of CNN-based model in predicting patients outcomes Shaunagh McDermott Massachusetts General Hospital NLST Jun 30, 2020 NLST-686
Development of computer-aided diagnosis systems for the lung disease in the chest radiograph Yoshiro Kitamura FUJIFILM corporation PLCO May 12, 2020 PLCOI-622
Development of Criteria and Standards for Use of Biorepository Specimens Edward Gelmann Georgetown University PLCO Jul 1, 2006 2006-0105
Development of DCNN-based solution for lung cancer detection based on CT images. Noé Samaille IBM NLST Mar 16, 2020 NLST-648
Development of Deep Learning algortihms for the automated Calcium Scoring identification from radiological studies Fernando Martin WellSpan Health NLST Apr 4, 2022 NLST-905
Development of deep learning frameworks based on pathology images for biomarker development Jennifer Beane Trustees of Boston University PLCO Jan 5, 2022 PLCOI-881
Development of deep-learning software for the detection, classification, and malignancy risk assessment of lung nodules on LDCT Kenneth Tang AIRdx NLST Aug 18, 2020 NLST-702
Development of diagnostic support software to aid clinical decision-making for lung disease Michael Calhoun Precision Medical Ventures, Inc. NLST Jun 14, 2021 NLST-800